Chapter 1

Question 0

brand name

Answer 0

name given to a drug by the pharmaceutical company that developed it; also called a trade name

Question 1

Adverse Effects

Answer 1

drug effects that are not the desired therapeutic effects; may be unpleasant or even dangerous

Question 2

chemical name

Answer 2

name that reflects the chemical structure of a drug

Question 3

drugs

Answer 3

chemicals that are introduced into the body to bring about some sort of change

Question 4

Food and Drug Administration (FDA)

Answer 4

federal agency responsible for regulation and enforcement of drug evaluation and distribution policies

Question 5

generic drugs

Answer 5

drugs sold by their generic name; not brand (or trade) name products

Question 6

Generic name

Answer 6

the original destination that a drug is given when the drug company that developed it applies for the approval process

Question 7

genetic engineering

Answer 7

process of altering DNA, usually of bacteria, to produce a chemical to be used as a drug

Question 8

orphan drugs

Answer 8

drugs that have been discovered but would not be profitable for a drug company to develop; usually drugs that would treat only a small number of people; these orphans can be adopted by drug companies to develop

Question 9

OTC; over the counter drugs

Answer 9

drugs that are available without a prescription for self treatment of a variety of complaints; deemed to be safe when used as directed

Question 10

pharmocology

Answer 10

the study of the biological effects of chemicals

Question 11

pharmacotherapeutics

Answer 11

clinical pharmacology - the branch of pharmacology that deals with drugs; chemicals that are used in medicine for the treatment, prevention, and diagnosis of disease in humans

Question 12

phase 1 study

Answer 12

a pilot study of a potential drug done with a small number of selected, healthy human volunteers

Question 13

phase II study

Answer 13

a clinical study of a proposed drug by selected physicians using actual patients who have the disorder the drug is designed to treat; patients must provide consent

Question 14

phase III study

Answer 14

use of a proposed drug on a wide scale inn the clinical setting with patients who have the disease the drug is thought to treat

Question 15

phase IV study

Answer 15

continual evaluation of a drug after it has been released forr marketing

Question 16

preclinical trials

Answer 16

initial trial of a chemical thought to have therapeutic potential; uses laboratory animals, not human subject

Question 17

teratogenic

Answer 17

having adverse effects on the fetus